NYSE:NPD - China Nepstar Chain Drugstore Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$2.55
Today's Range$2.55 - $2.55
52-Week Range$2.00 - $2.59
Average Volume61,544 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
China Nepstar Chain Drugstore Ltd. is a retail drugstore chain in China. The Company provides its customers with pharmacy services and a range of other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products, including consumable, seasonal and promotional items. The Company operates through the retail drugstore business segment. The Company also offers private label products. It has a network of approximately 1,990 directly operated drugstores spanning over 70 cities across approximately 14 provinces and direct-controlled municipalities in China. The Company offers approximately 2,170 private label products. The Company also operates an Internet Website, www.star365.com. It offers approximately 3,210 prescription drugs. It offers approximately 3,360 over-the-counter drugs, including western medicines and traditional Chinese medicines, for the treatment of common diseases.

Receive NPD News and Ratings via Email

Sign-up to receive the latest news and ratings for NPD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

China Nepstar Chain Drugstore (NYSE:NPD) Frequently Asked Questions

What is China Nepstar Chain Drugstore's stock symbol?

China Nepstar Chain Drugstore trades on the New York Stock Exchange (NYSE) under the ticker symbol "NPD."

How were China Nepstar Chain Drugstore's earnings last quarter?

China Nepstar Chain Drugstore Ltd. (NYSE:NPD) issued its quarterly earnings data on Wednesday, November, 25th. The company reported $0.00 earnings per share (EPS) for the quarter. The firm had revenue of $124.77 million for the quarter. View China Nepstar Chain Drugstore's Earnings History.

Has China Nepstar Chain Drugstore been receiving favorable news coverage?

News stories about NPD stock have been trending positive this week, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. China Nepstar Chain Drugstore earned a news impact score of 2.8 on InfoTrie's scale. They also gave news articles about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the near future.

How do I buy shares of China Nepstar Chain Drugstore?

Shares of NPD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact China Nepstar Chain Drugstore?

China Nepstar Chain Drugstore's mailing address is 6th Floor, Tower B, Xinnengyuan Building Nanhai Road Nanshan District, SHENZHEN, GNG 518057, China. The company can be reached via phone at +86-755-26435319.

MarketBeat Community Rating for China Nepstar Chain Drugstore (NYSE NPD)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  89
MarketBeat's community ratings are surveys of what our community members think about China Nepstar Chain Drugstore and other stocks. Vote "Outperform" if you believe NPD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NPD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel